SCHEMBL3260683

SCHEMBL3260683

Cc1c(Cl)nnc(N2CCN(c3cnc(C(=O)O)cn3)[C@H](C)C2)c1C

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMO Q99835 11/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1835617 0.89 SMO (0.70) SMO
SCHEMBL28899685 0.82 SMO (0.76) SMO
SCHEMBL3261532 0.82 SMO (1.00) SMO
SCHEMBL3206860 0.82 SMO (1.00) SMO
SCHEMBL28899656 0.82 SMO (0.85) SMO
SCHEMBL28899672 0.82 SMO (0.69) SMO
SCHEMBL3215871 0.81 SMO (0.68) SMO
SCHEMBL13534433 0.80 SMO (0.87) SMO
SCHEMBL13534030 0.80 SMO (1.00) SMO
SCHEMBL28899640 0.79 SMO (0.81) SMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318389-B1 PYRIDAZINE DERIVATIVES AS SMO INHIBITORS NOVARTIS AG (CH) 2013-06-19 EP disclosed
WO-2010007120-A1 PYRIDAZINE DERIVATIVES AS SMO INHIBITORS NOVARTIS AG (CH) 2010-01-21 WO disclosed